Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Precision Biosciences Inc
(NQ:
DTIL
)
9.690
-0.030 (-0.31%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Precision Biosciences Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Precision BioSciences Announces Investigational New Drug Clearance by Partner TG Therapeutics for Investigation of Azer-Cel for Multiple Sclerosis
August 09, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
7 Biotech Stocks to Buy for Their Game-Changing Potential
August 08, 2024
Although the market may be reeling from the recent fallout, the red ink presents a viable opportunity in these biotech stocks.
Via
InvestorPlace
Precision BioSciences Reports Second Quarter 2024 Financial Results and Provides Business Update
August 01, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Participate in Upcoming August Investor Conferences
July 31, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Deep Dive Into Precision BioSciences Stock: Analyst Perspectives (4 Ratings)
May 16, 2024
Via
Benzinga
Earnings Preview: Precision BioSciences
March 26, 2024
Via
Benzinga
Precision BioSciences to Report Second Quarter Results on August 1, 2024
July 29, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Present at the Upcoming JonesTrading Healthcare Seaside Summit
July 08, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces its Addition to the Russell Microcap® Index
July 01, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Presentation at UMDF Mitochondrial Medicine 2024 Supporting Advancement of PBGENE-PMM Program Towards IND and/or CTA in 2025
June 27, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Expands Hepatitis Scientific Advisory Board with Addition of World-Class Clinical Investigators Mark Sulkowski, M.D. and Jordan Feld, M.D., MPH, as PBGENE-HBV Program Nears Clinical Readiness
June 20, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Presents New Preclinical Safety Data for PBGENE-HBV Clinical Candidate at the European Association for the Study of the Liver Congress
June 05, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Participate in Upcoming June Investor Conferences
May 30, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
May 17, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
DTIL Stock Earnings: Precision BioSciences Beats EPS, Beats Revenue for Q1 2024
May 13, 2024
DTIL stock results show that Precision BioSciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Precision BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
May 13, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Common Stock Purchase by Members of Management for $300,000 in a Private Placement
May 08, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Report First Quarter Results on May 13, 2024
May 07, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Receipt of FDA Fast Track Designation for ECUR-506, iECURE’s Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency
May 07, 2024
From
Precision BioSciences
Via
Business Wire
Precision BioSciences Announces Late-Breaking Poster Presentation at the European Association for Study of the Liver (EASL) Congress 2024
May 01, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 17, 2024
Via
Benzinga
Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics
April 16, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
DTIL Stock Earnings: Precision BioSciences Misses EPS, Misses Revenue for Q4 2023
March 27, 2024
DTIL stock results show that Precision BioSciences missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
March 27, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Earnings Scheduled For March 27, 2024
March 27, 2024
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million.
Via
Benzinga
Precision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results on March 27, 2024
March 20, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Presents Preclinical Data Highlighting PBGENE-PMM as a Potential Therapy for Primary Mitochondrial Myopathy
March 19, 2024
From
Precision BioSciences
Via
Business Wire
Precision BioSciences Announces MHRA Approval for Partner iECURE to Expand Phase 1/2 Clinical Trial of ARCUS Gene Editing Program in OTC Deficiency
March 06, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
March 01, 2024
Via
Benzinga
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 01, 2024
Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.